NovaBay Pharmaceuticals, Inc. (NBY) - Medical Equipment - Deals and Alliances Profile

Date: October 20, 2014
Pages: 34
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: N81BFCF988BEN
Leaflet:

Download PDF Leaflet

NovaBay Pharmaceuticals, Inc. (NBY) - Medical Equipment - Deals and Alliances Profile
Summary

NovaBay Pharmaceuticals, Inc. (NovaBay) is a bio-pharmaceutical company. The company develops aganocide compounds. It offers treatments that tackle infections in the dermatology, urology, ophthalmology, and wound care areas. NovaBay's products include eye drops, treatment for contagious skin infection and impetigo. The company’s products are used in various therapeutic areas such as urology, dermatology, ophthalmology, and neutrophase. Its aganocides are synthetic anti-infectives designed to mimic the body’s defense against infection. The company provides clinical trials for UROvation and BAYnovation. It partners with Galderma, Pioneer Pharma, Virbac, Shin-Poong pharma and IHT. NovaBay is headquartered in Emeryville, California, the US.

NovaBay Pharmaceuticals, Inc. (NBY) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements: The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy: The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company: Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.: The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company: Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research: Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
NovaBay Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
NovaBay Pharmaceuticals, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014
NovaBay Pharmaceuticals, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014
NovaBay Pharmaceuticals, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014
NovaBay Pharmaceuticals, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014
NovaBay Pharmaceuticals, Inc., Medical Equipment, Deal Details
Shin Poong Enters Into Licensing Agreement With NovaBay For NeutroPhase
Equity Offering
NovaBay Pharma Prices Public Offering Of Common Stock And Warrants For US$6.7 Million
NovaBay Pharma Completes Registered Direct Offering Of US$5.16 Million
NovaBay Pharmaceuticals, Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Recent Developments
Financial Announcements
Jul 31, 2014: NovaBay Pharmaceuticals Reports Second Quarter 2014 Financial Results and a Clinical/Business Update
May 01, 2014: NovaBay Pharmaceuticals Reports First Quarter 2014 Financial Results and a Clinical/Business Update
Mar 07, 2014: NovaBay Pharmaceuticals Reports Fourth Quarter 2013 and 2013 Year End Financial Results and Provides a Clinical/Business Update
Nov 14, 2013: NovaBay Pharmaceuticals Reports Third Quarter 2013 Financial Results
Aug 01, 2013: NovaBay Pharmaceuticals Reports Second Quarter 2013 Financial Results and a Clinical/Business Update
May 02, 2013: NovaBay Pharma Reports Q1 2013 Results
Mar 14, 2013: NovaBay Pharma Reports Revenue Of $7m In 2012
Corporate Communications
Sep 18, 2014: NovaBay Pharmaceuticals Creates Optometry Advisory Board
Aug 28, 2014: NovaBay Pharmaceuticals Adds Five Top Ophthalmologists to its Ophthalmic Advisory Board
Jan 09, 2014: NovaBay Pharmaceuticals Appoints Mark M. Sieczkarek, Solta Medical Chairman and CEO and Dr. Massimo Radaelli, Noventia Pharma CEO to Its Board of Directors
Government and Public Interest
Jul 31, 2013: NovaBay Pharmaceuticals to Present at Southern California Investor Conference
Jul 03, 2013: NovaBay Pharmaceuticals To Present At Southern California Investor Conference
Jul 02, 2013: NovaBay Pharmaceuticals to Present at JMP Securities 8th Annual Healthcare Conference
Mar 12, 2013: NovaBay Pharmaceuticals to Present at the 25th Annual ROTH Conference
Product News
Apr 17, 2014: WoundSource Reports on the Role of NovaBay’s NeutroPhase in Treatment of ‘Flesh-Eating’ Infections
Mar 05, 2014: Interview with NovaBay CEO Highlights Prospects for the Company’s FDA-Cleared, Advanced Wound Cleanser, NeutroPhase, and its Development Pipeline
Feb 26, 2014: NovaBay Pharmaceuticals Grants Principle Business Enterprises Exclusive Marketing and Distribution Rights in the US for NeutroPhase, an Advanced Wound and Skin Cleanser
Feb 17, 2014: NovaBay's NeutroPhase is Best in Class in Laboratory Study of 19 Top Commercial Wound Cleansers
Feb 06, 2014: Dr. John Crew Gives Grand Rounds Presentation on Treating Wounds With NovaBay's NeutroPhase at Eisenhower Medical Center
Dec 11, 2013: NovaBay Pharmaceuticals Gains ISO 13485 Certification for the Design and Manufacturing of NeutroPhase
Clinical Trials
Feb 17, 2014: NovaBay's NeutroPhase is Best in Class in Laboratory Study of 19 Top Commercial Wound Cleansers
Other Significant Developments
Jan 08, 2014: NovaBay Pharmaceuticals Provides Business Unit Update and 2014 Outlook
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

NovaBay Pharmaceuticals, Inc., Medical Equipment, Key Facts, 2013
NovaBay Pharmaceuticals, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014
NovaBay Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
NovaBay Pharmaceuticals, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014
NovaBay Pharmaceuticals, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014
NovaBay Pharmaceuticals, Inc., Deals By Market, 2008 to YTD 2014
NovaBay Pharmaceuticals, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014
Shin Poong Enters Into Licensing Agreement With NovaBay For NeutroPhase
NovaBay Pharma Prices Public Offering Of Common Stock And Warrants For US$6.7 Million
NovaBay Pharma Completes Registered Direct Offering Of US$5.16 Million
NovaBay Pharmaceuticals, Inc., Key Competitors
NovaBay Pharmaceuticals, Inc., Key Employees

LIST OF FIGURES

NovaBay Pharmaceuticals, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014
NovaBay Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
NovaBay Pharmaceuticals, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014
NovaBay Pharmaceuticals, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014
NovaBay Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
NovaBay Pharmaceuticals, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014
NovaBay Pharmaceuticals, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014
NovaBay Pharmaceuticals, Inc., Medical Equipment, Deals by Market, 2008 to YTD 2014
Skip to top


Ask Your Question

NovaBay Pharmaceuticals, Inc. (NBY) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: